Loading...

TheraVet SA

ALVET.PA•EURONEXT
Healthcare
Biotechnology
€0.08
€0.00(0.00%)

TheraVet SA (ALVET.PA) Stock Overview

Explore TheraVet SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.8/100

Key Financials

Market Cap10M
P/E Ratio-0.17
EPS (TTM)$-0.48
ROE-0.32%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.02

ALVET.PA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of TheraVet SA (ALVET.PA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.02.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.17 and a market capitalization of 10M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;